RANCHO CORDOVA, Calif.,
March 10, 2021 /PRNewswire/ --
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in
automated cell processing tools and services in the cell and gene
therapy field, today announced that the Company will
release its financial results for the fourth quarter ended
December 31, 2020 and provide a
corporate strategic update on Wednesday,
March 17, 2021, after the close of trading. A conference
call and webcast will follow at 1:30 p.m.
PT/ 4:30 p.m. ET.
To participate in the conference call, please dial
1-844-889-4331 (domestic), 1-412-380-7406 (international)
or 1-866-605-3852 (Canada).
To access a live webcast of the call, please
visit: https://thermogenesis.com/investors/news-and-events/events-webcasts.
A webcast replay will be available on ThermoGenesis' website for
three months by visiting the Investor page of the Company's website
at www.thermogenesis.com.
About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. develops, commercializes, and
markets a range of automated technologies for CAR-T and other
cell-based therapies. The Company currently markets a full suite of
solutions for automated clinical biobanking, point-of-care
applications, and automation for immuno-oncology, including its
semi-automated, functionally-closed CAR-TXpress™ platform,
which streamlines the manufacturing process for the emerging CAR-T
immunotherapy market. For more information about ThermoGenesis,
please visit: www.thermogenesis.com.
Company Contact:
Wendy
Samford
916-858-5191
ir@ThermoGenesis.com
Investor Contact:
Paula Schwartz, Rx
Communications
917-322-2216
pschwartz@rxir.com
View original
content:http://www.prnewswire.com/news-releases/thermogenesis-holdings-to-announce-financial-results-for-the-fourth-quarter-ended-december-31-2020-and-provide-a-corporate-strategic-update-301244310.html
SOURCE ThermoGenesis Holdings, Inc.